Molecular Profiles announces it is to demonstrate its expansion of capabilities at the upcoming AAPS/FIP Pharmaceutical Sciences World Congress 2010.
Designed to provide a de-risking approach to drug development, the services, performed in one location, include formulation development activities with preformulation, polymorph screening, salt selection, analytical services and phase I clinical trial manufacturing, as well as existing state-of-the-art analytical and characterisation suites.
Molecular Profiles has provided specialised analytical and formulation services to major pharmaceutical companies for over a decade, with its expertise being called upon for complex pharmaceutical litigation issues globally. The company has worked on over 70 marketed products including over 20 blockbusters.
Nikin Patel, PhD MRPharmS, CEO of Molecular Profiles, commented: "The FIP and AAPS Congress will enable us to highlight our recent expansion activities, a process that we are continuing to invest in. We expect to make further announcements over the forthcoming months. Currently we have expanded our solid state analytical suite for polymorph and salt screening and we have brought on line clean rooms equipped with a range of standard and advanced formulation equipment. We are committed to bringing innovative scientific approaches to the rapid and pragmatic cost-effective development of formulations for phase I and beyond."
Underlining its scientific credentials, Molecular Profiles will also be presenting four posters at the congress:
. Derisking Early Stage Formulation Development of Poorly Water-Soluble Drugs by Screening at the Single Particulate Level
. Investigating Solid State Microstructure and Interactions in Lactose: PVP Pharmaceutical Granules
. Characterising the Surface Properties of Pharmaceutical Tooling Components with Atomic Force Microscopy
. A Novel Nanoscale Approach for Studying the Structure and Stability of Solid Dispersions
Molecular Profiles
